Search Within

Young-Mi Kim

Formats
  1. Journal Article (4)
  2. Meeting Abstract (2)
Groups
  1. Sloan Kettering Institute Postdocs (6)
  2. Department of Medicine (4)
  3. Solid Tumor Oncology Division (4)
  4. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (3)
  5. Biostatistics Service (2)
  6. Breast Medicine Service (2)

More Groups

People
  1. John Mendelsohn (2)
  2. Jose Baselga (2)
  3. Larry Norton (2)
  4. Axel Martin (1)
  5. Brett Carver (1)
  6. Charles Sawyers (1)

More People

Years
  1. 2020 (3)
  2. 2013 (1)
  3. 1998 (1)
  4. 1997 (1)
Publications
  1. Cancer Research (2)
  2. Clinical Cancer Research (1)
  3. European Journal of Cancer (1)
  4. Journal of Clinical Investigation (1)
  5. Molecular Cancer Research (1)
Publishers
  1. American Association for Cancer Research (4)
  2. American Society for Clinical Investigation (1)
  3. Elsevier Inc. (1)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Inhibiting eIF4A in liposarcoma to identify key regulators using ribosome profiling
    Meeting Abstract

    Mohan, P.; Kim, Y. M.
    European Journal of Cancer (2020)

    Fulltext@MSK | Save
  • Integrin-mediated mechano-transduction controls HER2 oncogenic signaling and activation of YAP in breast cancer
    Meeting Abstract

    Wang, S.; Kim, Y. M.; Garippa, R.; Norton, L.; Giancotti, F. G.
    Molecular Cancer Research (2020)

    Fulltext@MSK | Save
  • Rb and p53-deficient myxofibrosarcoma and undifferentiated pleomorphic sarcoma require Skp2 for survival
    Journal Article

    Li, G. Z.; Okada, T.; Kim, Y. M.; Agaram, N. P.; Sanchez-Vega, F.; Shen, Y.; Tsubokawa, N.; Rios, J.; Martin, A. S.; Dickson, M. A.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • β4 Integrin signaling induces expansion of prostate tumor progenitors
    Journal Article

    Yoshioka, T.; Otero, J.; Chen, Y.; Kim, Y. M.; Koutcher, J. A.; Satagopan, J.; Reuter, V.; Carver, B.; de Stanchina, E.; Enomoto, K.; more...
    Journal of Clinical Investigation (2013)

    Fulltext@MSK | Save
  • Recombinant humanized anti-HER2 antibody (Herceptin(TM)) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts
    Journal Article

    Baselga, J.; Norton, L.; Albanell, J.; Kim, Y. M.; Mendelsohn, J.
    Cancer Research (1998)

    Fulltext@MSK | Save
  • PD153035, a tyrosine kinase inhibitor, prevents epidermal growth factor receptor activation and inhibits growth of cancer cells in a receptor number- dependent manner
    Journal Article

    Bos, M.; Mendelsohn, J.; Kim, Y. M.; Albanell, J.; Fry, D. W.; Baselga, J.
    Clinical Cancer Research (1997)

    Fulltext@MSK | Save